Literature DB >> 22980319

Determination of bulleyaconitine A in plasma by a sensitive LC-MS/MS method and its application to an oral pharmacokinetic study in rats.

Qi Wang1, Bo Tan, Yijuan Gong, Guoxia Ji, Yun Zhang, Ping Yang, Wei Li, Teng Shen.   

Abstract

A sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of bulleyaconitine A (BLA) concentration in rat plasma. An aliquot of 100μL plasma sample was prepared by liquid-liquid extraction with diethyl ether. Chromatographic separation was accomplished on a Phenomenex Luna C(18) column (50mm×2.00mm, 5μm) utilizing a isocratic mobile phase consisting of (A) 0.1% formic acid in methanol and (B) formic acid in water. Detection was performed by multiple reaction monitoring (MRM) mode using electrospray ionization in the positive ion mode. The optimized fragmentation transitions for MRM were m/z 644.4→m/z 584.3 for BLA and m/z 632.4→m/z 572.3 for mesaconitine (IS). The method was linear over the concentration range of 0.02-20.0ng/mL. The intra and inter-day variance are less than 6.1% and accuracy is within ±9.0%. The validated method was successfully applied to pharmacokinetic study in rat after single oral administration of 40μg/kg of BLA and the oral pharmacokinetic data of BLA have been demonstrated for the first time.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22980319     DOI: 10.1016/j.jpba.2012.08.016

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Hydroxylation Metabolisms of Crassicauline A in Rats Under Toxic Dose.

Authors:  Xue Fan; Shan-Shan Yin; Xue-Jing Li; Kui Yang; Liang Xu; Ke Lan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.